Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzodiazepine derivatives as RSV inhibitors

Benzodiazepine derivatives as RSV inhibitors

US Patent 11390631 · Granted Jul 19, 2022

Estimated economic value: $12,675,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antiviral heterocyclic compounds2025
Hepatitis B antiviral agents2025
Spiropyrrolidine derived antiviral agents2025
Spiropyrrolidine derived antiviral agents2025
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods2025
Macrocyclic spiropyrrolidine derived antiviral agents2025
Macrocyclic spiropyrrolidine derived antiviral agents2025
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use there2025
Antiviral heterocyclic compounds2025
Antiviral heterocyclic compounds2025
Antiviral heterocyclic compounds2025
Benzodiazepine derivatives as RSV inhibitors2025